Braxia Scientific (TSE:BRAX) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Braxia Scientific, a medical research and telemedicine company, has announced that it will not meet the filing deadline for its annual financial statements and other required documents due to management changes, leading to an anticipated trading suspension. The company is actively seeking funding to cover audit expenses and aims to remedy the situation by September 15, 2024. Additionally, the company is in the process of replacing its recently resigned CFO and board member, Peter Rizakos.
For further insights into TSE:BRAX stock, check out TipRanks’ Stock Analysis page.